Defining the role of the SWI/SNF chromatin remodeling complex in advanced metastatic castration-resistant prostate cancer (mcrpc) therapy resistance…
Active Project Grant Awarded Last action
- Award ID
- HT94252410123
- Recipient
-
Universitat Bern UEI MX7JPQLVM5V5
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $989,167
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date 90% complete
- Place of performance
- Switzerland
Award details come from USAspending.gov.
About this award
The U.S. Defense Health Agency awarded a $989,167 Project Grant to the University of Bern in Switzerland under the Military Medical Research and Development program (CFDA 12.420). The grant, effective from February 15, 2024 to February 14, 2027, supports research to define the role of the SWI/SNF chromatin remodeling complex in advanced metastatic castration-resistant prostate cancer (mCRPC) therapy resistance. Through this grant, the University of Bern will conduct basic, translational, and clinical research to investigate innovative approaches for improving treatment of this challenging form of prostate cancer, which is a key priority for military medicine. The University of Bern frequently partners with U.S. institutions as a sub-awardee on major biomedical research projects funded by agencies like the National Institutes of Health.
Quick answers
Who received award HT94252410123?
HT94252410123 was awarded to Universitat Bern by Defense Health Agency (Department of Defense) on February 15, 2024.
How much is award HT94252410123 worth?
$989,167 has been obligated on HT94252410123.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award